<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03947398</url>
  </required_header>
  <id_info>
    <org_study_id>S61686</org_study_id>
    <nct_id>NCT03947398</nct_id>
  </id_info>
  <brief_title>The BLIMP Balloon in Coronary Interventions</brief_title>
  <official_title>A Prospective, Multi-Center Registry, Randomized Trial for Evaluation of Effectiveness of the Blimp Scoring Balloon in Lesions Not Crossable With Conventional Balloon or Microcatheter.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ziekenhuis Oost-Limburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AZ Sint-Jan AV</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>CHU de Charleroi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jolimont, La Louviere</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Universitaire Saint Pierre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Onze Lieve Vrouwziekenhuis Aalst</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Universitaire Dinant Godinne - UCL Namur</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Ghent</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Antwerp</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier du Luxembourg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effectivness of the Blimp Scoring balloon&#xD;
      compared to current available CTO balloon catheters.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For this study two case situations are being considered.&#xD;
&#xD;
      6.1.1 Case Situation A Guidewire crossed the lesion, micro catheter does not cross&#xD;
&#xD;
      Case situation A is the circumstansis where a physician is using a guidewire in combination&#xD;
      with a micro catheter. When in such case the guidewire is crossing at a certain moment of the&#xD;
      procedure and the micro catheter not a balloon crossing attempt is one of the current common&#xD;
      options as next step.&#xD;
&#xD;
      For the study the physician will go through following steps&#xD;
&#xD;
        1. select alternating in 50% of these cases his current first choice regular balloon (≤ 1.5&#xD;
           (mm) OD) and in the other 50% of cases the Blimp.&#xD;
&#xD;
        2. If first choice regular balloon does not cross select the Blimp and if the Blimp has&#xD;
           been first choice select regular first choice balloon.&#xD;
&#xD;
        3. If step 2 is not succesfull take a 6F guide extension and repeat sequence of step 1&amp;2.&#xD;
&#xD;
        4. If step 3 is also not succesfull report how else succeeded (e.g. tonus, balloon rupture,&#xD;
           carlino, rotablation, subintimal cross…) or not.&#xD;
&#xD;
      See also appendix I for a flow chart case situation A.&#xD;
&#xD;
      6.1.2 Case Situation B Small balloon catheter (≤ 1.5 (mm)) needed for procedure- no micro&#xD;
      catheter used.&#xD;
&#xD;
      Case situation B is the circumstansis where a physician is in the stage of a procedure where&#xD;
      he/ she would normally want to select a small balloon catheter ((≤ 1.5 (mm)) to cross an&#xD;
      occluded or subtotlal stenotic segment of the coronary artery. When in such case the balloon&#xD;
      catheter is not crossing the selection/ attempt with another balloon is one of the current&#xD;
      common options as next step.&#xD;
&#xD;
      For the study the physician will go through following steps&#xD;
&#xD;
        1. select alternating in 50% of these cases his current first choice regular balloon (≤ 1.5&#xD;
           (mm) OD) and in the other 50% of cases the Blimp.&#xD;
&#xD;
        2. If first choice regular balloon does not cross select the Blimp and if the Blimp has&#xD;
           been first choice select regular first choice balloon.&#xD;
&#xD;
        3. If step 2 is not succesfull take a 6F guide extension and repeat sequence of step 1&amp;2.&#xD;
&#xD;
        4. If step 3 is also not succesfull report how else succeeded (e.g. tonus, balloon rupture,&#xD;
           carlino, rotablation, subintimal cross…) or not.See also appendix I for a flow chart of&#xD;
           case situation B.&#xD;
&#xD;
      6.1.3 Use of the Blimp during the study&#xD;
&#xD;
      The Blimp should be used conform its Instruction For Use (IFU). Following techniques can be&#xD;
      attemted to cross the lesion.&#xD;
&#xD;
        1. Regular balloon crossing of lesion if no significant resistance is felt.&#xD;
&#xD;
        2. Application of distal force/ push to the tip of Blimp against the proximal cap of the&#xD;
           occlusion/subtotal lesion for 5-10 seconds to allow cap penetration due to spring&#xD;
           principle of Blimp shaft.&#xD;
&#xD;
        3. If no progressing in step 2 keep distal force/ push to the tip of the Blimp and inflate&#xD;
           to 25-30 ATM to attempt wedging/ scoring of the proximal cap.&#xD;
&#xD;
        4. Repeat step 2&amp;3 up to three times to see if proximal cap/ crossing progression is made.&#xD;
&#xD;
        5. If after multiple attemps of step 2&amp;3 no progression is demonstrated it should be&#xD;
           concluded that the Blimp was unsuccesfull in crossing.&#xD;
&#xD;
      6.1.4 Study population and number of subjects A total 128 patients which are being targeted&#xD;
      for percutaneous coronary intervention are selected for this study. Pased on power&#xD;
      calculations, 128 patiants are sufficient to demonstrate a statistical significant difference&#xD;
      in outcome (P&lt;0.05) with 80% power.&#xD;
&#xD;
      6.1.5 Inclusion/exclusion criteria Patients will be enrolled if they require percutaneous&#xD;
      coronary intervention (PCI) procedure and&#xD;
&#xD;
        1. During the case a micro catheter is being used which is not able to cross after crossing&#xD;
           of the guidewire (case situation A).&#xD;
&#xD;
        2. During the case a small balloon catheter (≤ 1.5 (mm) OD) is being used and is not able&#xD;
           to cross the target lesion (case situation B) .&#xD;
&#xD;
      Patients which under normal conditions would be excluded for a PCI procedure by the hospital&#xD;
      will be excluded from the study.&#xD;
&#xD;
      6.1.6 Rational and justification of chosen study design The Blimp is intended for balloon&#xD;
      dilatation of a coronary artery subtotal lesion/occlusions.&#xD;
&#xD;
      Due to its&#xD;
&#xD;
        -  very small profile&#xD;
&#xD;
        -  high rated burst pressure and&#xD;
&#xD;
        -  guidewire scoring element over the balloon&#xD;
&#xD;
      the device has several features which can improve the crossabiltiy and initial dilation of&#xD;
      severe occluded vessels. The study has been designed such to investigate in an objective and&#xD;
      controlled manner if the Blimp Scoring balloon is providing an improved procedural success&#xD;
      rate in these matters.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">March 28, 2019</start_date>
  <completion_date type="Anticipated">March 28, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 28, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Successful crossing through lesion and dilatation with BLIMP or low profile balloon</measure>
    <time_frame>The primary outcome is a procedural assessment</time_frame>
    <description>passing of BLIMP or low profile balloon through lesion. If device passess it will be determined a successful outcome, if it does not pass, an unsuccesful outcome.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Percutaneous Coronary Intervention</condition>
  <condition>Chronic Total Occlusion of Coronary Artery</condition>
  <arm_group>
    <arm_group_label>Treatment with BLIMP first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment with low-profile balloon first</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BLIMP balloon</intervention_name>
    <description>Using BLIMP balloon to cross lesion</description>
    <arm_group_label>Treatment with BLIMP first</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low profile balloon</intervention_name>
    <description>using low profile balloon to cross lesion</description>
    <arm_group_label>Treatment with low-profile balloon first</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Severe coronary lesion where microcatheter or dilatation balloon does not cross&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Johan Bennett</last_name>
    <phone>479293854</phone>
    <phone_ext>479293854</phone_ext>
    <email>johan.bennett@uzleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Johan Bennett</name>
      <address>
        <city>Leuven</city>
        <state>Brabant</state>
        <zip>3001</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johan Bennett</last_name>
      <phone>479293854</phone>
      <phone_ext>479293854</phone_ext>
      <email>johan.bennett@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Keir McCutcheon</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ZOL Genk</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joseph Dens, MD, PhD</last_name>
      <phone>+32 89 327193</phone>
      <email>jo.dens@zol.be</email>
    </contact>
    <contact_backup>
      <last_name>Nele Peeters</last_name>
      <phone>+32 89 327193</phone>
      <email>nele.peeters@zol.be</email>
    </contact_backup>
    <investigator>
      <last_name>Joseph Dens, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthias Vrolix, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Johan Van Lierde, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 28, 2019</study_first_submitted>
  <study_first_submitted_qc>May 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2019</study_first_posted>
  <last_update_submitted>May 10, 2019</last_update_submitted>
  <last_update_submitted_qc>May 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

